Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Shishov

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pediatric Rheumatology Online Journal|January 26, 2024
Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational studyKaleo Ede, Michael Shishov, Elisa Wershba, et al.
Rheumatic Diseases Clinics of North America|August 9, 2005
Pediatric-onset mixed connective tissue diseaseRichard J Mier, Michael Shishov, Gloria C Higgins, et al.
Arthritis and Rheumatism|August 1, 2007
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical settingSri Koneru, Michael Shishov, Avis Ware, et al.
Arthritis Care & Research|December 9, 2024
25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing ChallengesMichael Shishov, Pamela F Weiss, Deborah M Levy, et al.
Pediatric Rheumatology Online Journal|July 25, 2014
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registryRachel E Sobel, Daniel J Lovell, Hermine I Brunner, et al.
The Journal of Rheumatology|November 15, 2025
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic ArthritisJulia G Harris, Jade H Singleton, Tracy V Ting, et al.
Arthritis Care & Research|November 15, 2011
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conferenceAdam M Huber, Angela B Robinson, Ann M Reed, et al.
Arthritis Care & Research|June 12, 2023
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic ArthritisCatherine A Bingham, Julia G Harris, Tingting Qiu, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor TherapyNirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pediatric Rheumatology Online Journal|January 26, 2024
Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational studyKaleo Ede, Michael Shishov, Elisa Wershba, et al.
Rheumatic Diseases Clinics of North America|August 9, 2005
Pediatric-onset mixed connective tissue diseaseRichard J Mier, Michael Shishov, Gloria C Higgins, et al.
Arthritis and Rheumatism|August 1, 2007
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical settingSri Koneru, Michael Shishov, Avis Ware, et al.
Arthritis Care & Research|December 9, 2024
25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing ChallengesMichael Shishov, Pamela F Weiss, Deborah M Levy, et al.
Pediatric Rheumatology Online Journal|July 25, 2014
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registryRachel E Sobel, Daniel J Lovell, Hermine I Brunner, et al.
The Journal of Rheumatology|November 15, 2025
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic ArthritisJulia G Harris, Jade H Singleton, Tracy V Ting, et al.
Arthritis Care & Research|November 15, 2011
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conferenceAdam M Huber, Angela B Robinson, Ann M Reed, et al.
Arthritis Care & Research|June 12, 2023
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic ArthritisCatherine A Bingham, Julia G Harris, Tingting Qiu, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor TherapyNirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.
Pageof 2